Related Experiment Video
Updated: Feb 14, 2026

Simulator Training for Endovascular Neurosurgery
Published on: May 6, 2020
[Endovascular treatment of symptomatic carotid artery dissection]
Alfredo Fede1, Andrea Pacchioni1, Carlo Penzo1
1Divisione di Cardiologia, Ospedale Civile di Mirano (VE).
Insights
Internal carotid artery dissection can cause stroke in young adults. Endovascular stenting is a promising treatment option when medical therapy fails, especially in experienced centers.
Area of Science:
- Neurology
- Vascular Surgery
- Interventional Radiology
Background:
- Internal carotid artery dissection (ICAD) is a significant cause of stroke in young adults.
- Medical therapy for ICAD has limitations, necessitating exploration of alternative strategies.
- Optimal therapeutic strategies for symptomatic ICAD remain under debate.
Observation:
- A case of symptomatic ICAD successfully treated with an endovascular approach is presented.
- Recent literature on endovascular strategies for ICAD is reviewed.
- The technical aspects and procedural steps for endovascular treatment are detailed.
Findings:
- Endovascular treatment, particularly stenting, shows promise for ICAD.
- Stenting may be a valid therapeutic option when medical management is insufficient.
- Clinical experience and literature data support the efficacy of endovascular stenting.
Implications:
- Endovascular stenting should be considered a viable therapeutic strategy for ICAD.
- This approach may improve outcomes in patients with symptomatic ICAD.
- Further research in highly experienced centers can refine endovascular treatment protocols.
Abstract:
Internal carotid artery dissection is one of the possible causes of stroke in young adults. The effectiveness of medical therapy alone is often limited and endovascular strategy should be considered, particularly in the presence of persisting neurological symptoms. Currently, there is no general consensus on the most appropriate therapeutic strategy to follow in symptomatic carotid artery dissection. We here report a case of symptomatic carotid artery dissection treated with an endovascular approach, and we review the recent literature regarding this therapeutic strategy. Materials and methods for performing endovascular treatment are also described, along with the possible steps to follow. Data in the literature and our clinical experience suggest that stenting is promising in patients with internal carotid artery dissection and should be considered as a valid therapeutic strategy in case of failure of medical therapy in highly experienced centers.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
13:50Focal Cerebral Ischemia Model by Endovascular Suture Occlusion of the Middle Cerebral Artery in the Rat
Published on: February 5, 2011
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Arteries of Lower Limbs